发明名称 |
N-ETHYL-4-HYDROXYL-1-METHYL-5-(METHYL(2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO)-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE |
摘要 |
The subject invention provides pharmaceutical compositions Containing laquinimod or a pharmaceutically acceptable salt thereof, an isolated compound of N-ethyl-4-hydroxyl-1 -methyl-5- (methyl (2, 3,4,5, 6-pentahydroxyhexyl ) amino) -2-oxo-N-phenyl-1, 2- dihydroquinoline- 3 -carboxamide or a salt thereof, compositions containing N-ethyl-4-hydroxyl-1-methyl-5- (methyl (2,3,4,5,6- pentahydroxyhexyl ) amino) -2-oxo-N-phenyl-1, 2-dihydroquinoline-3- carboxamide and methods of preparing the same. |
申请公布号 |
WO2013169746(A2) |
申请公布日期 |
2013.11.14 |
申请号 |
WO2013US39911 |
申请日期 |
2013.05.07 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;LAXER, AVITAL;ULANENKO, KONSTANTIN |
发明人 |
LAXER, AVITAL;ULANENKO, KONSTANTIN |
分类号 |
C07D215/56;A61K31/4704 |
主分类号 |
C07D215/56 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|